Literature DB >> 21279596

Magnetic resonance safety.

Andrew Simmons1, Kristina Hakansson.   

Abstract

The safe operation of both clinical and pre-clinical MR systems is critical. There are a wide range of potential MR hazards. This chapter covers both the theoretical background to issues of MR safety and the guidance on more practical issues. The main sources of information on national and international MR safety guidance and advice are discussed, as well as local safety policies which are required for all MR installations. The projectile effect and other MR safety issues due to static and time-varying magnetic fields are considered, such as peripheral nerve stimulation, tissue heating and RF burns. Finally, contrast agents, auditory effects and medical implants and devices are discussed, as well as the less thought about issue of biological safety of clinical and pre-clinical MR systems.

Mesh:

Year:  2011        PMID: 21279596     DOI: 10.1007/978-1-61737-992-5_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Magnetic resonance safety.

Authors:  Steffen Sammet
Journal:  Abdom Radiol (NY)       Date:  2016-03

2.  Investigation of Factors Affecting Body Temperature Changes During Routine Clinical Head Magnetic Resonance Imaging.

Authors:  Myeong Seong Kim
Journal:  Iran J Radiol       Date:  2016-07-04       Impact factor: 0.212

3.  Neural Basis of Action Observation and Understanding From First- and Third-Person Perspectives: An fMRI Study.

Authors:  Sheng Ge; Hui Liu; Pan Lin; Junfeng Gao; Chaoyong Xiao; Zonghong Li
Journal:  Front Behav Neurosci       Date:  2018-11-22       Impact factor: 3.558

4.  Methodology for Low-Field, Portable Magnetic Resonance Neuroimaging at the Bedside.

Authors:  Anjali M Prabhat; Anna L Crawford; Mercy H Mazurek; Matthew M Yuen; Isha R Chavva; Adrienne Ward; William V Hofmann; Nona Timario; Stephanie R Qualls; Juliana Helland; Charles Wira; Gordon Sze; Matthew S Rosen; William Taylor Kimberly; Kevin N Sheth
Journal:  Front Neurol       Date:  2021-12-10       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.